Published by Persistence MarketResearch
Posted on October 12, 2021
5 min readLast updated: January 29, 2026
The Animal Health API market is set to grow significantly, reaching $9,162.2 Mn by 2025, driven by APAC and Europe, despite quality and regulatory challenges.
The Animal Health Active Pharmaceutical Ingredients Market is destined to reach US$ 4,600 Million at a CAGR of 7.3% between 2025. The healthcare vertical is moving the gadget-way. The current scenario is such that one need not make appointments for weeks/months for being treated. The real-time diagnosis and course of treatment could be possible. This simultaneous monitoring and treatment are bound to take the healthcare industry by storm in the next 10 years.
The global animal health active pharmaceutical ingredient (API) market is projected to register an impressive expansion at 7.3% CAGR during the forecast period 2017 to 2025, according to a recent study by Persistence Market Research (PMR). PMR’s study estimates the market to increase from revenues worth US$ 5,216.1 Mn in 2017 to reach US$ 9,162.2 Mn by 2025-end.
Planning Forward? Access Sample Of Animal Health Active Pharmaceutical Ingredients Market Report! https://www.persistencemarketresearch.co/samples/16972
Company Profiles
Limited Insurance or Government Intervention Provides Smooth Flow to the Market Growth in APAC
Asia Pacific (APAC) will continue to be the most lucrative region in the global animal health active pharmaceutical ingredient market, with sales exhibiting the second highest CAGR through 2025. APAC has remained one of the largest API suppliers, at affordable costs.
Governments across APAC have been making investments and focusing on local manufacturing facilities of APIs. Favorable policies offered by these governments have been shifting the focus of API manufacturers in moving their production bases to APAC countries, such as India and China.
In addition, limited insurance or government intervention provides smooth flow to market growth in these regions.
However, animal health API products manufactured in APAC countries do not meet regulatory standards, and there has been increasing concerns pertaining to the quality of APIs, especially those produced in China and India. Western regulatory bodies are becoming stricter in the inspection of APIs produced in these regions.
Manufacturers are further facing challenges in bridging the gap between the cost and quality of APIs. These factors will inhibit growth of the market in APAC.
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Animal Health Active Pharmaceutical Ingredients Market? https://www.persistencemarketresearch.co/methodology/16972
Europe to Remain the Second Largest Market for Animal Health APIs
Europe will remain the second largest market for animal health active pharmaceutical ingredients. Leading healthcare companies are located in the Europe, which in turn has boosted requirement for veterinary APIs in the region. Consumption of veterinary drugs in Europe has surged substantially over the past few years. Spain has been witnessed to be the largest consumer of veterinary antimicrobial APIs in the EU.
In addition, rising improvements in the animal productivity has driven growth of the animal health industry in this region. These incidences are expected to augment growth of the animal health API market in Europe.
However, the pharmaceutical industry in Europe has been concerned with potential short-term impacts of REACH regulations. This is likely to result in decreased supply of materials, or reagents, which are not preregistered by EU suppliers.
Planning To Introduce An Offbeat Product/Technology In The Animal Health Active Pharmaceutical Ingredients Market? Go To “Purchase Now” To Have Our Animal Health Active Pharmaceutical Ingredients Market Report! https://www.persistencemarketresearch.com/checkout/16972
In addition, dynamic changes in Europe’s macro-economic environment, such as the Brexit, has been impacting the intra-European trade and overall pharmaceutical sector. These factors might curb growth of the animal health API market in Europe.
Antiparasitics to Remain the Largest Adopted APIs in the Market
Antiparasitics will continue to be the largest adopted API in the market, followed by anti-infectives. Sales of Antiparasitics are expected to register the fastest expansion, to account for the largest revenues by 2025-end. In contrast, revenues from sales of anesthetics and NSAIDs will remain comparatively lower than antiparasitics and anti-infectives.
Access Related Reports-
Global Market Study on Veterinary Anti-Infectives: Antiparasitic Agents Segment Expected to be the Least Attractive Segment by Drug Class
Global Market Study on Animal Drug Compounding: CNS Agents to Lead Market Expansion Over Coming Years
Global Market Study on Animal Healthcare: Industry Growth to Be Driven by Veterinary Hospitals
Global Market Study on Animal Parasiticides: Pharmacies and Drug Stores Distribution Channel Segment Expected to Register High Revenue Growth Through 2026
About Us:-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
The post Animal Health Active Pharmaceutical Ingredients Market Outlook and Opportunities in Grooming Regions appeared first on Lake Shore Gazette.
The article discusses the growth and opportunities in the Animal Health Active Pharmaceutical Ingredients market.
APAC and Europe are highlighted as key regions for API production, with APAC being a major supplier.
The market faces challenges such as quality concerns for APIs from APAC and regulatory hurdles in Europe.
Explore more articles in the Research Reports category
